COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.
-
Upload
ophelia-gardner -
Category
Documents
-
view
213 -
download
1
Transcript of COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.
![Page 1: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/1.jpg)
COPD
Aaqid Akram MBChB (2013)Clinical Education Fellow
![Page 2: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/2.jpg)
Objectives
• What is it?• How to diagnose it• How to assess severity/progression• How to manage it – Stable/Exacerbation
![Page 3: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/3.jpg)
What is it?
• Chronic Bronchitis/emphysema• Non reversible airflow obstruction• Progressive airway and parenchymal damage• Chronic inflammation• Smoking• Alpha-1-antitrypsin• 3 million in UK (900 000 diagnosed)
![Page 4: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/4.jpg)
How to diagnose it
• >35 years old• Smokers• SOBOE• Chronic cough• Regular sputum
production• Frequent winter
“bronchitis”• Wheeze
• Weight loss• Reduced exercise
tolerance• Waking at night• Ankle swelling• Fatigue• Occupational hazards• Chest pain• Haemoptysis
![Page 5: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/5.jpg)
MRC Dyspnoea Score
Grade Degree of breathlessness related to activities
1 SOB on strenuous exercise
2 SOB on hurrying or walking uphill
3 Walks slower than contemporaries due to SOB /Has to stop for breath at normal walking pace
4 Stops for breath walking 100 metres / few minutes on level ground
5 Cannot leave house / SOB on (un)dressing
![Page 6: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/6.jpg)
Lung volumes
![Page 7: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/7.jpg)
Spirometry
• Predicted• Pre + Post bronchodilator therapy. (>400ml)• FEV1• FVC• FEV1/FVC• Obstructive• Restrictive
![Page 8: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/8.jpg)
Volume (L)
Time (s)
5
4
6
2
3
1
0 1 8765432
Normal
Obstructive
Restrictive
FEV1
FVC
![Page 9: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/9.jpg)
Flow Volume MeasurementExp Flow Rate (L/s)
Volume (L)
Maximal Expiratory Flow
Forced Vital Capacity
![Page 10: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/10.jpg)
Other Tests
• CXR• BMI• FBC – polycythaemia/anaemia• ? Alpha-1-antitrypsin (Age)• Pulse Oximetry• Sputum Culture (persistently purulent)• PEFR (to exclude asthma)
![Page 11: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/11.jpg)
COPD v AsthmaCOPD Asthma
(Ex) Smoker
Age <35
Chronic productive cough
SOB
Nigh time waking SOB/wheeze
Diurnal/day to day variability
Think Asthma if:• Large response to bronchodilator/prednisolone (>400 ml)• Serial PEFR shows >20% diurnal/day to day variation
It is not significant COPD if FEV1 and FEV1/FVC ratio return to normal with Drug Rx
![Page 12: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/12.jpg)
Prognosis (BODE Index)
BMI, Airflow Obstruction (Post bronchodilator), Dyspnoea, Exercise Capacity
0 1 2 3
B BMI >21 <22
O FEV1% Predicted >64 50-64 36-49 <36
D MMRC dyspnoea scale 0/1 2 3 4
E 6 Min Walk Distance (m) >349 250-349 150-249 <150
![Page 13: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/13.jpg)
SeverityPost
Bronchodilator FEV1/FVC
Predicted FEV1 % Severity of Airflow Obstruction
<0.7 >79 Stage 1 Mild (symptoms required)
<0.7 50-79 Stage 2 Moderate
<0.7 30-49 Stage 3 Severe
<0.7 <30 (<50 + RF) Stage 4 Very Severe
![Page 14: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/14.jpg)
When to Refer?
• Diagnostic uncertainty
• Severe COPD• Second Opinion• O2 Rx assessment• Cor Pulminale• Long term Neb• Long term PO steroid
• Bullous lung disease• Rapid FEV1 decline• Pulmonary rehab• Lung transplant• <40 years old• Frequent Infections• Haemoptysis• Symptoms > deficit
![Page 15: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/15.jpg)
![Page 16: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/16.jpg)
Management
• Smoking Cessation – NRT / Bupropion / Varenicicline / Support
• Nutrition – supplements• Anxiety / Depression• Physiotherapy – breathing techniques /
expectoration. • Pulmonary rehabilitation• Vaccinations – pneumococcal / influenza• Air travel – LTOT / FEV1<50% / pneumothorax
![Page 17: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/17.jpg)
Inhaled Rx
(LABA+ICS) + LAMA
LABA or LAMA (FEV1>50%) / (LABA+ICS) or LAMA (FEV1<50%)
SABA or SAMA
![Page 18: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/18.jpg)
Drug Type Generic Name Brand Name Colour
Short Acting Beta₂ Agonist (SABA) Salbutamol Salamol/Ventolin Blue
Terbutaline Bricanyl Blue
Long Acting Beta₂ Agonist (LABA) Indacaterol Onbrez Green
Salmeterol Serevent Green
Short Acting Muscarinic Antagonist (SAMA) Ipratropium Atrovent/Respontin/Rinatec
Long Acting Muscarinic Antagonist (LAMA) Tiotropium Spiriva
Glycopyrronium Seebri
Aclidinium Eklira Genuair
Inhaled Corticosteroid (ICS) Beclomethasone Clenil Modulite/QVAR Brown
Budesonide Flixotide Brown
Fluticasone Pulmicort Brown
LABA+ICS (one inhaler) Formeterol/Budesonide Symbicort Red
Salmeterol/Fluticasone Seretide Purple
Vilanterol/Fluticasone Relvar Ellipta Yellow
![Page 19: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/19.jpg)
Oral Rx
• Methylxanthines – (Theo/Amino)phylline• Corticosteroids – not routinely recommended• Mucolytic therapy – Carbocisteine • Prophylactic Abx – not recommended• Phosphodiesterase 4 inhibitors – if on trials
![Page 20: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/20.jpg)
Long Term O2 Therapy
• LTOT – 15 to 20 hours per day• Stable + PaO2 < 7.3 kPa• Stable + PaO2< 8 kPa + one of:– Secondary polycythaemia– Nocturnal hypoxaemia– Peripheral oedema– Pulmonary hypertension
![Page 21: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/21.jpg)
![Page 22: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/22.jpg)
Pulmonary Hypertension/Cor Pulmonale
• Pulmonary hypertension:– Increased blood pressure in lung vasculature
• Cor Pulmonale: – Right heart failure due to lungs– Due to sustained pulmonary hypertension– Symptoms of back pressure –
SOB/Chronic wet cough/Wheezing/Raised JVP + engorged facial veins/ Hepatomegaly/Peripheral oedema/Ascities/Parasternal heave/Loud pulm 2nd HS
![Page 23: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/23.jpg)
Exacerbation of COPD
?Need for NIV / HDU / ICU
Abx if pyrexial, purulent sputum or evidence of consolidation
Prescribe and administer steroids – 30mg prednisolone/100mh hydrocortisone
IV access + FBC/U+E
ECG
CXR
Check ABG – change O2 accordingly
Salbutamol 5mg + Ipratropium 500mcg nebs (air driven)
O2 (88-92%)
ABCDE
![Page 24: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/24.jpg)
Non Invasive Ventilation
• Bi-Level Ventilatory support• Potentially reversible exacerbation• Type 2 RF• Respiratory acidosis (pH<7.36 / PaCO2>5.9)• Despite Max medical Rx for 1 hour• Able to co-operate with mask• IPAP – 10• EPAP – 4
![Page 25: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/25.jpg)
![Page 26: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/26.jpg)
NIV – Exclusion Criteria/CI
• Pneumothorax • End stage malignancy • Acute myocardial infarction • Multi-organ failure • Cranio-facial abnormalities/Trauma• Normo-capnoeic metabolic acidosis • Impaired consciousness (GCS <8)• Patient declines use – refused consent• Haemodynamically Unstable• Irreversible condition• Unable to Co-operate with mask/no improvement
Consider ICU Input
![Page 27: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/27.jpg)
Any Questions?
Basically…. Smoking’s bad for you
![Page 28: COPD Aaqid Akram MBChB (2013) Clinical Education Fellow.](https://reader035.fdocuments.us/reader035/viewer/2022062805/5697bfa31a28abf838c9671a/html5/thumbnails/28.jpg)
Objectives Were:
• What is it?• How to diagnose it• How to assess severity/progression• How to manage it – Stable/Exacerbation